BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28091697)

  • 21. Molecular Mechanism of HSF1-Upregulated ALDH2 by PKC in Ameliorating Pressure Overload-Induced Heart Failure in Mice.
    Ji E; Jiao T; Shen Y; Xu Y; Sun Y; Cai Z; Zhang Q; Li J
    Biomed Res Int; 2020; 2020():3481623. PubMed ID: 32626739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload.
    Zou Y; Pan L; Shen Y; Wang X; Huang C; Wang H; Jin X; Yin C; Wang Y; Jia J; Qian J; Zou Y; Gong H; Ge J
    Cell Death Dis; 2021 Sep; 12(10):877. PubMed ID: 34564708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects.
    Cannon MV; Yu H; Candido WM; Dokter MM; Lindstedt EL; Silljé HH; van Gilst WH; de Boer RA
    Eur J Heart Fail; 2015 Mar; 17(3):273-82. PubMed ID: 25684370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol.
    Nishiga M; Horie T; Kuwabara Y; Nagao K; Baba O; Nakao T; Nishino T; Hakuno D; Nakashima Y; Nishi H; Nakazeki F; Ide Y; Koyama S; Kimura M; Hanada R; Nakamura T; Inada T; Hasegawa K; Conway SJ; Kita T; Kimura T; Ono K
    Circ Res; 2017 Mar; 120(5):835-847. PubMed ID: 27920122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy.
    Sakamoto M; Minamino T; Toko H; Kayama Y; Zou Y; Sano M; Takaki E; Aoyagi T; Tojo K; Tajima N; Nakai A; Aburatani H; Komuro I
    Circ Res; 2006 Dec; 99(12):1411-8. PubMed ID: 17095722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoter.
    Shu HY; Peng YZ; Hang WJ; Zhang M; Shen L; Wang DW; Zhou N
    Acta Pharmacol Sin; 2022 Oct; 43(10):2550-2561. PubMed ID: 35217815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of HSF1-upregulated AC6 in ameliorating heart failure in mice.
    The E; Du P; Chang Y; Dai F; Wei C; Li J
    Environ Toxicol Pharmacol; 2016 Oct; 47():79-85. PubMed ID: 27643574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.
    Li J; Levick SP; DiPette DJ; Janicki JS; Supowit SC
    Regul Pept; 2013 Aug; 185():20-8. PubMed ID: 23816470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.
    Wang JH; Su F; Wang S; Lu XC; Zhang SH; Chen D; Chen NN; Zhong JQ
    Int J Clin Exp Pathol; 2014; 7(10):6514-23. PubMed ID: 25400729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of HSP90 S-nitrosylation alleviates cardiac fibrosis via TGFβ/SMAD3 signalling pathway.
    Zhang X; Zhang Y; Miao Q; Shi Z; Hu L; Liu S; Gao J; Zhao S; Chen H; Huang Z; Han Y; Ji Y; Xie L
    Br J Pharmacol; 2021 Dec; 178(23):4608-4625. PubMed ID: 34265086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1/p38 signaling in mice.
    Wu L; Mei L; Chong L; Huang Y; Li Y; Chu M; Yang X
    Life Sci; 2016 Jan; 145():121-6. PubMed ID: 26706286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.
    Yuan J; Liu H; Gao W; Zhang L; Ye Y; Yuan L; Ding Z; Wu J; Kang L; Zhang X; Wang X; Zhang G; Gong H; Sun A; Yang X; Chen R; Cui Z; Ge J; Zou Y
    Theranostics; 2018; 8(9):2565-2582. PubMed ID: 29721099
    [No Abstract]   [Full Text] [Related]  

  • 35. EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling.
    Su SA; Yang D; Wu Y; Xie Y; Zhu W; Cai Z; Shen J; Fu Z; Wang Y; Jia L; Wang Y; Wang JA; Xiang M
    Circ Res; 2017 Sep; 121(6):617-627. PubMed ID: 28743805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collaborative Regulation of LRG1 by TGF-β1 and PPAR-β/δ Modulates Chronic Pressure Overload-Induced Cardiac Fibrosis.
    Liu C; Lim ST; Teo MHY; Tan MSY; Kulkarni MD; Qiu B; Li A; Lal S; Dos Remedios CG; Tan NS; Wahli W; Ferenczi MA; Song W; Hong W; Wang X
    Circ Heart Fail; 2019 Dec; 12(12):e005962. PubMed ID: 31830829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of heat shock factor 1 promotes hepatic stellate cell activation and drives liver fibrosis.
    Choudhury A; Ratna A; Lim A; Sebastian RM; Moore CL; Filliol AA; Bledsoe J; Dai C; Schwabe RF; Shoulders MD; Mandrekar P
    Hepatol Commun; 2022 Oct; 6(10):2781-2797. PubMed ID: 35945902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
    Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
    J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astaxanthin attenuated pressure overload-induced cardiac dysfunction and myocardial fibrosis: Partially by activating SIRT1.
    Zhang J; Wang QZ; Zhao SH; Ji X; Qiu J; Wang J; Zhou Y; Cai Q; Zhang J; Gao HQ
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1715-1728. PubMed ID: 28300638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress.
    Kazakov A; Hall RA; Werner C; Meier T; Trouvain A; Rodionycheva S; Nickel A; Lammert F; Maack C; Böhm M; Laufs U
    Basic Res Cardiol; 2018 Sep; 113(6):42. PubMed ID: 30191336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.